Reports for PURDUE PHARMA
Company Name
PURDUE PHARMA
Totals |
||
Shortage reports |
140 |
|
| Actual shortage: | 0 (0%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 1 (1%) | |
| Resolved: | 139 (99%) | |
Discontinuation Reports |
5 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 5 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
0 (0%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CODEINE CONTIN 50MG CONTROLLED RELEASE TAB | 50MG | TABLET (EXTENDED-RELEASE) | Avoided shortage | 2021-08-13 | 2021-08-24 | 144124 |
| CODEINE CONTIN 50MG CONTROLLED RELEASE TAB | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-12-02 | 2021-12-22 | 150354 |
| CODEINE CONTIN 50MG CONTROLLED RELEASE TAB | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-10-27 | 2023-01-12 | 172772 |
| CODEINE CONTIN 50MG CONTROLLED RELEASE TAB | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-05-18 | 2023-06-10 | 192720 |
| CODEINE CONTIN 50MG CONTROLLED RELEASE TAB | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-07-27 | 2023-09-09 | 200267 |
| CODEINE CONTIN 50MG CONTROLLED RELEASE TAB | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-11-01 | 2024-01-05 | 208850 |
| DILAUDID | 4MG | TABLET | Resolved | 2021-01-19 | 2021-03-11 | 132013 |
| DILAUDID | 4MG | TABLET | Resolved | 2021-03-31 | 2021-04-16 | 136608 |
| DILAUDID | 4MG | TABLET | Resolved | 2021-06-24 | 2021-09-02 | 141430 |
| OXYNEO | 40MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-02-17 | 2022-04-12 | 155189 |
| OXYNEO | 40MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-04-28 | 2023-05-11 | 191123 |
| ZYTRAM XL | 400MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-05-18 | 2021-06-05 | 139568 |
| ZYTRAM XL | 400MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-04-01 | 2023-02-03 | 157716 |
| HYDROMORPH CONTIN | 4.5MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2021-06-03 | 2021-07-09 | 140262 |
| HYDROMORPH CONTIN | 4.5MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2021-07-21 | 2021-08-12 | 142841 |
| HYDROMORPH CONTIN | 4.5MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2022-06-23 | 2022-07-04 | 163380 |
| HYDROMORPH CONTIN | 4.5MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2022-10-27 | 2022-11-17 | 172766 |
| HYDROMORPH CONTIN | 4.5MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2022-12-15 | 2023-01-17 | 178602 |
| HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 3MG | 3MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2021-01-25 | 2021-02-18 | 132378 |
| HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 3MG | 3MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2021-03-03 | 2021-03-16 | 135014 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| BELBUCA | 75MCG | FILM, SOLUBLE | Discontinued | 2019-03-28 | 2019-04-02 | 79766 |
| BELBUCA | 450MCG | FILM, SOLUBLE | Discontinued | 2019-04-01 | 2019-04-02 | 80236 |
| BELBUCA | 300MCG | FILM, SOLUBLE | Discontinued | 2019-04-01 | 2019-04-02 | 80233 |
| DILAUDID | 1MG | Discontinued | 2018-03-01 | 2018-03-02 | 41479 | |
| BELBUCA | 150MCG | FILM, SOLUBLE | Discontinued | 2019-04-01 | 2019-04-02 | 80230 |
Showing 1 to 5 of 5